According to a fresh Series posted in The Lancet

Actions needed to prevent violence against women and girls Current efforts to prevent violence against women and girls are inadequate, according to a fresh Series posted in The Lancet. Estimates globally suggest that, 1 in 3 women provides experienced either physical or sexual violence from their partner, and that 7 percent of women will encounter sexual assault by a non-partner at some point in their lives . Yet, despite increased global attention to violence perpetrated against women and women, and recent improvements in knowledge about how to deal with these abuses, levels of violence against females – including intimate partner violence, rape, feminine genital mutilation, trafficking, and forced marriages – stay unacceptably high, with serious consequences for victims' physical and mental health.

Related StoriesKolltan announces display of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015Allergan settles patent litigation with Amneal related to NAMENDA XR expanded discharge capsulesFDA accepts Chiasma's NDA filing for octreotide capsules for treatment of adult sufferers with acromegaly Endo and Grunenthal GmbH filed match against Actavis on January 18, 2013, in the U.S. District Court for the Southern District of New York wanting to prevent Actavis from commercializing its ANDA product before the expiration of certain U.S. Patents.S. Sales of approximately $512 million according to IMS Health data.. Actavis seeks FDA acceptance to market generic Opana ER Watson Pharmaceuticals, Inc.